(19)
(11) EP 2 049 113 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
03.11.2010 Bulletin 2010/44

(45) Mention of the grant of the patent:
26.05.2010 Bulletin 2010/21

(21) Application number: 07766491.0

(22) Date of filing: 03.07.2007
(51) International Patent Classification (IPC): 
A61K 31/501(2006.01)
 A61P 25/28(2006.01)
(86) International application number:
PCT/HU2007/000059
(87) International publication number:
WO 2008/004013 (10.01.2008 Gazette 2008/02)

(54)

MEDICAMENT FOR THE ENHANCEMENT OF COGNITIVE FUNCTION AND NEUROPROTECTION

MEDIKAMENT ZUR VERBESSERUNG DER KOGNITIVEN FUNKTION UND NEUROPROTEKTION

MÉDICAMENT POUR L'AMÉLIORATION D'UNE FONCTION COGNITIVE ET LA NEUROPROTECTION

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 03.07.2006 HU 0600555

(43) Date of publication of application:
22.04.2009 Bulletin 2009/17

(73) Proprietor: EGIS Gyógyszergyár Nyrt
1106 Budapest (HU)

(72) Inventors:
  • GACSALYI, István
    H-1201 Budapest (HU)
  • GIGLER, Gábor
    H-1119 Budapest (HU)
  • AGOSTON, Márta
    H-1173 Budapest (HU)
  • KOMPAGNE, Hajnalka
    H-1221 Budapest (HU)
  • KERTESZ, Szabolcs
    H-2151 Fót (HU)
  • MORICZ, Krisztina
    H-1071 Budapest (HU)
  • LEVAY, György
    H-2092 Budakeszi (HU)
  • SZENASI, Gábor
    H-2096 Üröm (HU)
  • HARSING, László, Gábor
    H-1071 Budapest (HU)
  • BARKOCZY, József
    H-1016 Budapest (HU)
  • SIMIG, Gyula
    H-1126 Budapest (HU)

(74) Representative: Beszédes, Stephan G. 
Patentanwalt Münchener Strasse 80a
85221 Dachau
85221 Dachau (DE)


(56) References cited: : 
WO-A-01/17993
WO-A-03/010166
WO-A-03/091244
 WO-A-98/15541
WO-A-03/042212
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).